Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000115303 | SCV000149212 | likely benign | not provided | 2022-11-30 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001081917 | SCV000555818 | likely benign | Bloom syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321589 | SCV002607377 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000115303 | SCV004222473 | likely benign | not provided | 2022-11-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001081917 | SCV001461114 | likely benign | Bloom syndrome | 2018-07-26 | no assertion criteria provided | clinical testing |